Takeda Aims for Consecutive Sales Growth through FY2022

October 31, 2014
Takeda President Christophe Weber (right) Takeda Pharmaceutical President Christophe Weber said on October 30 that the company aims to achieve a continual sales increase through FY2022 with the growth of innovative drugs, generics, and OTC drugs that will outpace the...read more